LAFYX
Price
$20.55
Change
+$0.07 (+0.34%)
Updated
Sep 8 closing price
Net Assets
6.27B
VVIAX
Price
$71.07
Change
-$0.12 (-0.17%)
Updated
Sep 8 closing price
Net Assets
202.84B
Interact to see
Advertisement

LAFYX vs VVIAX

Header iconLAFYX vs VVIAX Comparison
Open Charts LAFYX vs VVIAXBanner chart's image
Lord Abbett Affiliated I
Price$20.55
Change+$0.07 (+0.34%)
VolumeN/A
Net Assets6.27B
Vanguard Value Index Adm
Price$71.07
Change-$0.12 (-0.17%)
VolumeN/A
Net Assets202.84B
LAFYX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LAFYX vs. VVIAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAFYX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. LAFYX (6.27B). VVIAX pays higher dividends than LAFYX: VVIAX (2.10) vs LAFYX (1.63). LAFYX was incepted earlier than VVIAX: LAFYX (27 years) vs VVIAX (25 years). LAFYX (0.44) is less costly to investors than VVIAX (0.05). LAFYX is a more actively managed with annual turnover of: 44.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than LAFYX: VVIAX (3000) vs LAFYX (1000000). LAFYX annual gain was more profitable for investors over the last year : 9.47 vs. VVIAX (7.74). VVIAX return over 5 years is better than : 70.16 vs. LAFYX (56.31).
LAFYXVVIAXLAFYX / VVIAX
Total Expense Ratio0.440.05880%
Annual Report Gross Expense Ratio0.440.05880%
Fund Existence27 years25 years-
Gain YTD10.1477.850129%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets6.27B203B3%
Annual Yield % from dividends1.632.1078%
Returns for 1 year9.477.74122%
Returns for 3 years33.8236.6192%
Returns for 5 years56.3170.1680%
Returns for 10 years56.37131.6143%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity